Introduction

This page provides a comprehensive analysis of the known insider trading history of Emil D Kakkis. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Emil D Kakkis has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:RARE / Ultragenyx Pharmaceutical Inc. President & CEO, Director 641,731
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Emil D Kakkis. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Trading History

This table shows the complete list of insider trades made by Emil D Kakkis as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-03-04 2025-03-03 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale -73,434 641,731 -10.27 42.10 -3,091,571 27,016,875
2025-03-04 2025-03-01 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
A - Award 107,292 715,165 17.65
2025-03-04 2025-03-01 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
A - Award 43,268 607,873 7.66
2025-03-04 2025-02-28 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale -25,000 2,158,985 -1.14 42.48 -1,062,000 91,713,683
2024-12-31 2024-12-30 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale -11,727 2,183,985 -0.53 42.23 -495,231 92,229,687
2024-12-11 2024-12-10 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale -8,273 2,195,712 -0.38 50.00 -413,650 109,785,600
2024-12-11 2024-12-09 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
G - Gift -20,000 2,203,985 -0.90
2024-09-05 2024-09-03 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale -20,000 2,223,985 -0.89 55.85 -1,117,000 124,209,562
2024-08-07 2024-08-06 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale -20,000 2,243,985 -0.88 50.17 -1,003,400 112,580,727
2024-03-05 2024-03-01 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
A - Award 3,132 563,913 0.56
2024-03-05 2024-03-01 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
F - Taxes -17,417 560,781 -3.01 53.69 -935,119 30,108,332
2024-03-05 2024-03-01 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
A - Award 38,428 578,198 7.12
2024-02-08 2024-02-07 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -30,000 539,770 -5.27 45.00 -1,350,000 24,289,650
2024-01-02 2023-12-29 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -30,000 569,770 -5.00 47.87 -1,436,100 27,274,890
2023-10-23 2023-10-19 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale -47,853 599,743 -7.39 33.52 -1,604,033 20,103,385
2023-10-23 2023-10-19 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
M - Exercise X 47,853 647,029 7.99 6.86 328,272 4,438,619
2023-03-03 2023-03-01 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
F - Taxes -16,140 599,176 -2.62 45.65 -736,791 27,352,384
2023-03-03 2023-03-01 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
A - Award 46,200 615,606 8.11
2023-03-03 2023-03-01 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
A - Award 8,716 569,406 1.55
2023-01-03 2022-12-30 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -19,582 541,108 -3.49 45.57 -892,352 24,658,292
2022-03-03 2022-03-01 4 RARE Ultragenyx Pharmaceutical Inc.
Stock Option (Right to Buy)
A - Award 92,360 92,360
2022-03-03 2022-03-01 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
A - Award 52,041 634,226 8.94
2022-03-03 2022-03-01 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
F - Taxes -12,162 582,185 -2.05 67.37 -819,354 39,221,803
2022-02-01 2021-12-10 5 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
G - Gift -50,000 2,209,741 -2.21
2021-10-18 2021-10-14 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
F - Taxes -853 594,347 -0.14 81.00 -69,093 48,142,107
2021-05-10 2021-05-06 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
F - Taxes -852 595,200 -0.14 115.71 -98,585 68,870,592
2021-05-05 2021-05-03 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -30,000 2,259,741 -1.31 107.80 -3,234,000 243,600,080
2021-03-03 2021-03-01 4 RARE Ultragenyx Pharmaceutical Inc.
Stock Option (Right to Buy)
A - Award 36,000 36,000
2021-03-03 2021-03-01 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -30,000 2,289,741 -1.29 141.80 -4,254,000 324,685,274
2021-03-03 2021-03-01 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
F - Taxes -16,342 596,052 -2.67 142.47 -2,328,245 84,919,528
2021-03-03 2021-03-01 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
A - Award 15,453 612,394 2.59
2021-03-03 2021-03-01 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
A - Award 18,000 596,941 3.11
2021-02-03 2020-11-27 5 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
G - Gift -31,248 578,941 -5.12
2021-02-03 2020-11-19 5 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
G - Gift -10,000 2,349,741 -0.42
2021-02-03 2020-05-27 5 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
G - Gift -40,422 578,941 -6.53
2021-02-03 2020-05-22 5 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
G - Gift -100,000 2,349,741 -4.08
2021-01-05 2021-01-04 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -30,000 2,329,741 -1.27 136.90 -4,107,000 318,941,543
2020-11-04 2020-11-02 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -30,000 2,359,741 -1.26 96.82 -2,904,600 228,470,124
2020-10-16 2020-10-14 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
F - Taxes -852 610,189 -0.14 92.69 -78,972 56,558,418
2020-09-02 2020-09-01 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -30,000 2,389,741 -1.24 82.63 -2,478,900 197,464,299
2020-07-15 2020-07-13 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -40,000 2,419,741 -1.63 85.35 -3,414,000 206,524,894
2020-06-03 2020-06-01 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
F - Taxes -1,334 611,041 -0.22 69.38 -92,553 42,394,025
2020-05-08 2020-05-06 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
F - Taxes -852 652,797 -0.13 66.26 -56,454 43,254,329
2020-04-21 2020-04-19 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
F - Taxes -851 653,649 -0.13 58.57 -49,843 38,284,222
2020-03-13 2020-03-12 4 RARE Ultragenyx Pharmaceutical Inc.
Warrant (Right to Buy)
X - Other -66,533 0 -100.00
2020-03-13 2020-03-12 4 RARE Ultragenyx Pharmaceutical Inc.
Warrant (Right to Buy)
X - Other -83,167 0 -100.00
2020-03-13 2020-03-12 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
X - Other 66,533 654,500 11.32 3.01 199,998 1,967,427
2020-03-13 2020-03-12 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
X - Other 83,167 587,967 16.48 3.01 250,000 1,767,429
2020-03-03 2020-03-01 4 RARE Ultragenyx Pharmaceutical Inc.
Stock Option (Right to Buy)
A - Award 56,100 56,100
2020-03-03 2020-03-01 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
F - Taxes -6,896 504,800 -1.35 56.08 -386,728 28,309,184
2020-03-03 2020-03-01 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
A - Award 18,782 511,696 3.81
2020-03-03 2020-03-01 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
A - Award 17,000 492,914 3.57
2019-10-16 2019-10-14 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
A - Award 3,435 475,914 0.73
2019-09-11 2019-09-11 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
P - Purchase 5,000 472,479 1.07 43.63 218,150 20,614,259
2019-06-04 2019-06-01 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
F - Taxes -1,327 467,479 -0.28 54.93 -72,892 25,678,621
2019-05-22 2019-05-21 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
F - Taxes -1,414 468,806 -0.30 59.50 -84,133 27,893,957
2019-05-07 2019-05-06 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
A - Award 3,435 470,220 0.74
2019-04-23 2019-04-19 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
F - Taxes -798 466,785 -0.17 64.43 -51,415 30,074,958
2019-04-17 2019-03-05 4/A RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale -2,890 467,583 -0.61 65.52 -189,353 30,636,038
2019-04-17 2019-03-01 4/A RARE Ultragenyx Pharmaceutical Inc.
Stock Option (Right to Buy)
A - Award 66,000 66,000
2019-04-17 2019-03-01 4/A RARE Ultragenyx Pharmaceutical Inc.
Common Stock
A - Award 20,000 470,473 4.44
2019-03-04 2019-03-01 4 RARE Ultragenyx Pharmaceutical Inc.
Stock Option (Right to Buy)
A - Award 66,000 66,000
2019-03-04 2019-03-01 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
F - Taxes -2,802 467,670 -0.60 67.55 -189,275 31,591,108
2019-03-04 2019-03-01 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
A - Award 20,000 470,472 4.44
2018-06-04 2018-06-01 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
F - Taxes -926 450,472 -0.21 73.73 -68,274 33,213,301
2018-05-22 2018-05-21 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
F - Taxes -986 451,398 -0.22 64.79 -63,883 29,246,076
2018-04-19 2018-04-19 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
A - Award 3,429 452,384 0.76
2018-03-05 2018-03-01 4 RARE Ultragenyx Pharmaceutical Inc.
Stock Option (Right to Buy)
A - Award 94,500 94,500
2018-03-05 2018-03-01 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
F - Taxes -1,114 448,955 -0.25 48.43 -53,951 21,742,891
2018-03-05 2018-03-01 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
A - Award 19,500 450,069 4.53
2017-08-29 2017-08-28 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
P - Purchase 1,647 2,559,741 0.06 52.96 87,225 135,563,883
2017-08-29 2017-08-28 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
P - Purchase 5,853 2,558,094 0.23 52.40 306,697 134,044,126
2017-06-01 2017-06-01 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
F - Taxes -1,006 430,569 -0.23 56.61 -56,950 24,374,511
2017-05-22 2017-05-21 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
F - Taxes -1,072 431,575 -0.25 57.47 -61,608 24,802,615
2017-03-01 2017-03-01 4 RARE Ultragenyx Pharmaceutical Inc.
Employee Stock Option (Right to Buy)
A - Award 78,000 78,000
2017-03-01 2017-03-01 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
A - Award 13,000 432,647 3.10
2017-02-10 2016-12-22 5 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
G - Gift -27,500 419,647 -6.15
2016-11-17 2016-11-15 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -200 447,147 -0.04 83.01 -16,602 37,117,672
2016-11-17 2016-11-15 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -4,180 447,347 -0.93 82.36 -344,265 36,843,499
2016-11-17 2016-11-15 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -7,755 451,527 -1.69 81.55 -632,420 36,822,027
2016-11-17 2016-11-15 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -6,451 459,282 -1.39 80.64 -520,209 37,036,500
2016-11-17 2016-11-15 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -1,414 465,733 -0.30 79.39 -112,257 36,974,543
2016-10-18 2016-10-14 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -1,800 467,147 -0.38 64.78 -116,604 30,261,783
2016-10-18 2016-10-14 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -2,345 468,947 -0.50 64.41 -151,041 30,204,876
2016-10-18 2016-10-14 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -9,340 471,292 -1.94 63.06 -588,980 29,719,674
2016-10-18 2016-10-14 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -6,515 480,632 -1.34 61.97 -403,735 29,784,765
2016-08-17 2016-08-15 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -6,097 487,147 -1.24 68.12 -415,328 33,184,454
2016-08-17 2016-08-15 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -13,903 493,244 -2.74 67.39 -936,923 33,239,713
2016-07-19 2016-07-15 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -6,450 507,147 -1.26 51.34 -331,143 26,036,927
2016-07-19 2016-07-15 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -13,550 513,597 -2.57 50.61 -685,766 25,993,144
2016-06-03 2016-06-01 4 RARE Ultragenyx Pharmaceutical Inc.
Employee Stock Option (Right to Buy)
A - Award 63,700 63,700
2016-06-03 2016-06-01 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
A - Award 10,700 527,147 2.07
2016-05-24 2016-05-21 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
F - Taxes -1,072 516,447 -0.21 64.01 -68,619 33,057,772
2016-05-18 2016-05-16 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -200 517,519 -0.04 61.93 -12,386 32,049,952
2016-05-18 2016-05-16 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -2,595 517,719 -0.50 61.34 -159,177 31,756,883
2016-05-18 2016-05-16 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -6,390 520,314 -1.21 60.32 -385,445 31,385,340
2016-05-18 2016-05-16 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -10,815 526,704 -2.01 59.37 -642,087 31,270,416
2016-04-19 2016-04-15 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -5,376 537,519 -0.99 71.06 -382,019 38,196,100
2016-04-19 2016-04-15 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -9,834 542,895 -1.78 70.35 -691,822 38,192,663
2016-04-19 2016-04-15 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -4,790 552,729 -0.86 69.46 -332,713 38,392,556
2016-02-12 2015-12-18 5 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
G - Gift -18,121 557,519 -3.15
2016-01-04 2015-12-31 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -605 575,640 -0.10 114.61 -69,339 65,974,100
2016-01-04 2015-12-31 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -2,702 576,245 -0.47 113.83 -307,569 65,593,968
2016-01-04 2015-12-31 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -2,191 578,947 -0.38 112.91 -247,386 65,368,906
2016-01-04 2015-12-30 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -2,600 581,138 -0.45 116.31 -302,406 67,592,161
2016-01-04 2015-12-30 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -3,600 583,738 -0.61 115.56 -416,016 67,456,763
2016-01-04 2015-12-30 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -5,465 587,338 -0.92 114.61 -626,344 67,314,808
2016-01-04 2015-12-30 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -2,837 592,803 -0.48 113.30 -321,432 67,164,580
2015-12-02 2015-11-30 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -1,415 595,640 -0.24 99.42 -140,679 59,218,529
2015-12-02 2015-11-30 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -11,374 597,055 -1.87 98.62 -1,121,704 58,881,564
2015-12-02 2015-11-30 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -5,261 608,429 -0.86 97.88 -514,947 59,553,031
2015-12-02 2015-11-30 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -1,950 613,690 -0.32 96.46 -188,097 59,196,537
2015-11-03 2015-10-30 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -1,900 615,640 -0.31 101.20 -192,280 62,302,768
2015-11-03 2015-10-30 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -4,400 617,540 -0.71 100.43 -441,892 62,019,542
2015-11-03 2015-10-30 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -7,600 621,940 -1.21 99.42 -755,592 61,833,275
2015-11-03 2015-10-30 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
S - Sale X -6,100 629,540 -0.96 98.63 -601,643 62,091,530
2015-05-27 2015-05-21 4 RARE Ultragenyx Pharmaceutical Inc.
Stock Option (Right to Buy)
A - Award 68,300 68,300
2015-05-27 2015-05-21 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
A - Award 11,400 635,640 1.83
2014-03-28 2014-02-05 4/A RARE Ultragenyx Pharmaceutical Inc.
Warrant to Purchase Common Stock (Right to Buy)
J - Other 83,167 0 -100.00
2014-03-28 2014-02-05 4/A RARE Ultragenyx Pharmaceutical Inc.
Warrant to Purchase Series A Preferred Stock (Right to Buy)
J - Other -260,688 0 -100.00
2014-02-07 2014-02-05 4 RARE Ultragenyx Pharmaceutical Inc.
Warrant to Purchase Common Stock (Right to Buy)
J - Other 41,583 0 -100.00
2014-02-07 2014-02-05 4 RARE Ultragenyx Pharmaceutical Inc.
Warrant to Purchase Series A Preferred Stock (Right to Buy)
J - Other -130,344 0 -100.00
2014-02-07 2014-02-05 4 RARE Ultragenyx Pharmaceutical Inc.
Warrant to Purchase Common Stock (Right to Buy)
J - Other 24,950 0 -100.00
2014-02-07 2014-02-05 4 RARE Ultragenyx Pharmaceutical Inc.
Warrant to Purchase Series A Preferred Stock (Right to Buy)
J - Other -78 0 -100.00
2014-02-07 2014-02-05 4 RARE Ultragenyx Pharmaceutical Inc.
Warrant to Purchase Common Stock (Right to Buy)
J - Other 83,039 0 -100.00
2014-02-07 2014-02-05 4 RARE Ultragenyx Pharmaceutical Inc.
Warrant to Purchase Series A Preferred Stock (Right to Buy)
J - Other -260,688 0 -100.00
2014-02-07 2014-02-05 4 RARE Ultragenyx Pharmaceutical Inc.
Series A Preferred Stock
C - Conversion -1,956,686 0 -100.00
2014-02-07 2014-02-05 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
C - Conversion 624,240 624,240
2014-01-30 3 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
2,552,241
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)